Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is -1.05% vs 4.32% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 399.62% vs -135.25% in Mar 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "210.84",
          "val2": "213.08",
          "chgp": "-1.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.24",
          "val2": "48.94",
          "chgp": "21.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.62",
          "val2": "6.45",
          "chgp": "-12.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-52.81",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "47.01",
          "val2": "-15.69",
          "chgp": "399.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "28.10%",
          "val2": "22.97%",
          "chgp": "5.13%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Symbiotec Pharma"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Symbiotec Pharma"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Symbiotec Pharma"
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ

Jun'26

Mar'26

Change(%)

Net Sales

210.84

213.08

-1.05%

Operating Profit (PBDIT) excl Other Income

59.24

48.94

21.05%

Interest

5.62

6.45

-12.87%

Exceptional Items

0.00

-52.81

100.00%

Standalone Net Profit

47.01

-15.69

399.62%

Operating Profit Margin (Excl OI)

28.10%

22.97%

5.13%

Values in Rs Cr.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2026 is -1.05% vs 4.32% in Mar 2026

Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 399.62% vs -135.25% in Mar 2026

All Quarterly Results